Table 1.
Studies of conservative strategy following complete clinical response to neoadjuvant chemotherapy of muscle-invasive bladder cancer.
| Study | No. of patient who achieved cCR | Median follow-up | Recurrence rate | Outcome | References |
|---|---|---|---|---|---|
| Harry (2008) | 63 | 86 | 30% | 5-year OS: 64% | (71) |
| Meyer (2014) | 32 | NA | 52% | 5-year CSS: 88% | (72) |
| Robins (2017) | 48 | 35 | 46% | 5-year OS: 87% | (73) |
| Mazza (2018) | 148 | 55 | 48% | 5-year OS: 86% | (19) |
| 5-year CSS: 90% | |||||
| Onishi (2021) | 58 | 40 | 36% | 5-year OS: 89% | (74) |
cCR, complete clinical response; OS, overall survival; CSS, cancer-specific survival.